Acute on Chronic Liver Failure: Definition and Implications

被引：3
作者：
Aday, Ariel [1 ]
O'Leary, Jacqueline G. [1 ,2 ]
机构：
[1] Univ Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Dallas Vet Affairs Med Ctr, 4500 South Lancaster Rd, Dallas, TX 75216 USA
来源：
CLINICS IN LIVER DISEASE | 2020年 / 24卷 / 03期
关键词：
Acute on chronic liver failure; Cirrhosis; Dysbiosis; Organ failure; Liver transplant; ACUTE KIDNEY INJURY; BETA-BLOCKERS; BACTERIAL-INFECTIONS; CONSENSUS RECOMMENDATIONS; PACIFIC ASSOCIATION; CIRRHOSIS; MORTALITY; MANAGEMENT; SURVIVAL; GUT;
D O I：
10.1016/j.cld.2020.04.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Acute on chronic liver failure (ACLF) is an inflammation-based disorder that occurs in patients with underlying liver disease and is characterized by hepatic and extrahepatic organ failure. Morbidity and mortality are high in patients with ACLF, and therefore prevention and early identification are critical to improve outcome. The purpose of this article is to define ACLF, describe ways to identify the expected outcome of ACLF after development, and illustrate interventions to prevent it and when it is not preventable reduce associated morbidity and mortality.
引用
收藏
页码：521 / +
页数：15
相关论文
共 69 条
  • [51] Piano S, 2020, CLIN GASTROENTEROL H
  • [52] Gut Microbiota: Its Role in Hepatic Encephalopathy
    Rai, Rahul
    Saraswaty, Vivek A.
    Dhiman, Radha K.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 : S29 - S36
  • [53] Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
    Reiberger, Thomas
    Ferlitsch, Arnulf
    Payer, Berit A.
    Mandorfer, Mattias
    Heinisch, Birgit B.
    Hayden, Hubert
    Lammert, Frank
    Trauner, Michael
    Peck-Radosavljevic, Markus
    Vogelsang, Harald
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 911 - 921
  • [54] Roland BC, 2013, J CLIN GASTROENTEROL, V47, P888, DOI 10.1097/MCG.0b013e31829006bb
  • [55] Rosenblatt R, 2018, HEPATOLOGY, V68, p301A
  • [56] Management of Adult Patients with Ascites Due to Cirrhosis: An Update
    Runyon, Bruce A.
    [J]. HEPATOLOGY, 2009, 49 (06) : 2087 - 2107
  • [57] Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome
    Sargenti, Konstantina
    Prytz, Hanne
    Strand, Anna
    Nilsson, Emma
    Kalaitzakis, Evangelos
    [J]. LIVER INTERNATIONAL, 2015, 35 (02) : 391 - 400
  • [58] Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
    Sarin, Shiv Kumar
    Kumar, Ashish
    Almeida, John A.
    Chawla, Yogesh Kumar
    Fan, Sheung Tat
    Garg, Hitendra
    de Silva, H. Janaka
    Hamid, Saeed Sadiq
    Jalan, Rajiv
    Komolmit, Piyawat
    Lau, George K.
    Liu, Qing
    Madan, Kaushal
    Mohamed, Rosmawati
    Ning, Qin
    Rahman, Salimur
    Rastogi, Archana
    Riordan, Stephen M.
    Sakhuja, Puja
    Samuel, Didier
    Shah, Samir
    Sharma, Barjesh Chander
    Sharma, Praveen
    Takikawa, Yasuhiro
    Thapa, Babu Ram
    Wai, Chun-Tao
    Yuen, Man-Fung
    [J]. HEPATOLOGY INTERNATIONAL, 2009, 3 (01) : 269 - 282
  • [59] Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites
    Serste, Thomas
    Melot, Christian
    Francoz, Claire
    Durand, Francois
    Rautou, Pierre-Emmanuel
    Valla, Dominique
    Moreau, Richard
    Lebrec, Didier
    [J]. HEPATOLOGY, 2010, 52 (03) : 1017 - 1022
  • [60] Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
    Seymour, Christopher W.
    Gesten, Foster
    Prescott, Hallie C.
    Friedrich, Marcus E.
    Iwashyna, Theodore J.
    Phillips, Gary S.
    Lemeshow, Stanley
    Osborn, Tiffany
    Terry, Kathleen M.
    Levy, Mitchell M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) : 2235 - 2244
1234567